

Will the U.S. healthcare system achieve a technological breakthrough, or will another promising tool die on the vine due to medicine’s illogical financial model?
That was the question I set out to answer this morning from the main stage of the 10th annual Accountable Care Symposium in Orlando, Florida—an event hosted by Wellvana, one of the nation’s leading value-based care providers. The gathering brought together hundreds of healthcare professionals and policy leaders from across the country at a pivotal moment for medicine.
For the first time, we have a technology—generative AI—that holds the power to make healthcare affordable for all Americans by improving patient health and reducing medical errors—not by restricting access or compromising clinical outcomes.
But unless we pair that technology with the right payment model, its potential will remain unrealized.